Pricing Log in Create free account
Friday 6 November 2026 Export SNY’s income statement to Excel — free account

Sanofi

SNY Healthcare Drug Manufacturers General

Sanofi’s revenue for fiscal 2025 (year ended December 2025) was $52.9 billion, up 10.3% from fiscal 2024.

Revenue
+13.9%
EPS
+8.21%
Free cash flow
+99.6%
Total debt
−11.2%

Quarter to September 2026, against a year earlier

46.81 0.66 −1.39%
Market cap
$111.8B
P/E
23.2×
Fwd P/E
—
Dividend yield
5.18%
F-score
7/9
Altman Z
2.50
Beneish M
−2.63
Dividend safety
54/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Sanofi (SNY) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Sanofi (SNY) trades at a EV/EBITDA of 11.4×. Over the past ten years it has ranged from 5.9× (March 2020) to 20.7× (September 2024); the current reading is higher than 32% of that period. That is below the Drug Manufacturers General industry median of 14.8× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 13.3× (15.95%)
FY2024 15.8× 13.64%
FY2023 13.9× 15.35%
FY2022 12.1× 72.94%
FY2021 7.0× (5.99%)
FY2020 7.4× (0.09%)
FY2019 7.4× (34.66%)
FY2018 11.4× (30.04%)
FY2017 16.2× 7.51%
FY2016 15.1× (1.56%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 10.2× (11.76%)
Jun 2026 11.5× (13.30%)
Mar 2026 13.3× 0.19%
Dec 2025 13.3× 1.46%
39 more quarters

Against its own ten years

Low 5.9× High 20.7×
Ten-year median 13.0×
Current reading's percentile 32

EV/EBITDA against peers

Company EV/EBITDA
NVO Novo Nordisk A/S compare 7.3×
GSK GSK PLC Sponsored ADR compare 10.6×
PFE Pfizer Inc. compare 10.9×
BMY Bristol Myers Squibb Company compare 11.3×
SNY Sanofi 11.4×
AZN AstraZeneca PLC compare 14.8×
NVS Novartis AG compare 15.6×
AMGN Amgen Inc. compare 17.6×
GILD Gilead Sciences, Inc. compare 505×
Drug Manufacturers General industry median 14.8×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on SNY